JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dingwell, R. T.
Right arrow Articles by Bagg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dingwell, R. T.
Right arrow Articles by Bagg, R.
J. Dairy Sci. 86:159-168
© American Dairy Science Association, 2003.

Efficacy of Intramammary Tilmicosin and Risk Factors for Cure of Staphylococcus aureus Infection in the Dry Period

R. T. Dingwell*, K. E. Leslie*, T. F. Duffield*, Y. H. Schukken{dagger}, L. DesCoteaux{ddagger}, G. P. Keefe§, D. F. Kelton*, K. D. Lissemore*, W. Shewfelt||, P. Dick# and R. Bagg#

* University of Guelph, Guelph, Ontario N1G 2W1, Canada
{dagger} Quality Milk Promotion Services, Cornell Univesity, Ithaca New York 14850-1263 USA
{ddagger} University of Montreal, St. Hyacinthe, Quebec J2S 7C6 Canada
§ University of Prince Edward Island, Charlottetown, P.E.I. C1A 4P3 Canada
|| Tavistock Veterinarians, 25 Hope St. East Tavistock, Ontario, N0B 2R0
# Provel, Division of Eli Lilly Canada Inc., Research Park Centre, Guelph, Ontario N1G 4T2 Canada

Corresponding author:
R. T. Dingwell; e-mail:
rdingwell{at}vet.k-state.edu.

The objective of this study was to evaluate the efficacy of intramammary tilmicosin, administered at drying-off, for eliminating Staphylococcus aureus infection, and to identify risk factors for S. aureus cure during the dry period. A total of 219 naturally infected cows, representing 308 quarters, were randomized to receive either one of two treatments at drying-off. Cows received either an intramammary infusion of 500 mg of benzathine cloxacillin, or a sterile solution containing 1500 mg of tilmicosin. All cows had quarter milk samples taken aseptically three times before dry-off, and at wk 1, 2, and 4 of the subsequent lactation. Overall, 62% of cows and 67.5% of quarters infected with S. aureus cured during the dry period. The cure following administraton of tilmicosin was 67.3 and 72.5% for cows and quarters, respectively. By comparison, the cure achieved with cloxacillin was 56.9 and 62.9% of cows and quarters. Cows receiving tilmicosin were 2.1 times more likely to cure. The cure rate for cows decreased as the linear score on the last DHI test increased, and as the amount of S. aureus being shed increased. Quarters that cultured positive multiple times before drying-off were less likely to cure. Staphylococcus aureus infections located in front quarters of the udder were 2 times more likely to cure than those in hind quarters. Results of this study demonstrate that intramammary tilmicosin at drying-off is efficacious in curing existing S. aureus during the dry period. Risk factors associated with the cure of S. aureus were identified.

Key Words: Staphylococcus aureus • dry cow therapy • tilmicosin

Abbreviation key: CNS = coagulase-negative staphylococci, CP5 = capsular polysaccharide 5, DCT = dry cow antibiotic therapy, LS = linear score, OR = odds ratio




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J. J. Gill, J. C. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and P. M. Sabour
Efficacy and Pharmacokinetics of Bacteriophage Therapy in Treatment of Subclinical Staphylococcus aureus Mastitis in Lactating Dairy Cattle.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2912 - 2918.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
O. Reksen, L. Solverod, A. J. Branscum, and O. Osteras
Relationships between milk culture results and treatment for clinical mastitis or culling in Norwegian dairy cattle.
J Dairy Sci, August 1, 2006; 89(8): 2928 - 2937.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
H. W. Barkema, Y. H. Schukken, and R. N. Zadoks
Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis.
J Dairy Sci, June 1, 2006; 89(6): 1877 - 1895.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. K. M. Nair, J. Joy, P. Vasudevan, L. Hinckley, T. A. Hoagland, and K. S. Venkitanarayanan
Antibacterial Effect of Caprylic Acid and Monocaprylin on Major Bacterial Mastitis Pathogens
J Dairy Sci, October 1, 2005; 88(10): 3488 - 3495.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
H. A. Deluyker, S. N. Van Oye, and J. F. Boucher
Factors Affecting Cure and Somatic Cell Count After Pirlimycin Treatment of Subclinical Mastitis in Lactating Cows
J Dairy Sci, February 1, 2005; 88(2): 604 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. M. Sabour, J. J. Gill, D. Lepp, J. C. Pacan, R. Ahmed, R. Dingwell, and K. Leslie
Molecular Typing and Distribution of Staphylococcus aureus Isolates in Eastern Canadian Dairy Herds
J. Clin. Microbiol., August 1, 2004; 42(8): 3449 - 3455.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Dairy Science Association ®.